Production, purification, and crystallization of the recombinant HER2 tyrosine kinase domain (HER2-TKD). [PDF]
Topalan E, Çiftçi H, Demirci H.
europepmc +1 more source
<i>DNMT3A</i> Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups. [PDF]
Duca F +8 more
europepmc +1 more source
TKD characterization of low dimensional materials [PDF]
Bastos S. Fanta, Alice; id_orcid 0000-0002-1753-029X +6 more
openaire
Dynamical simulation of on-axis transmission Kikuchi and spot diffraction patterns, based on accurate diffraction geometry calibration. [PDF]
Zhang T +3 more
europepmc +1 more source
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70. [PDF]
Hachani K +17 more
europepmc +1 more source
Molecular Heterogeneity of Core Binding Factor Acute Myeloid Leukemia (CBF-AML): Implications for Prognosis and for Treatment. [PDF]
Testa U, Cerchione C.
europepmc +1 more source
FLT3 inhibitors in AML: from classic scaffolds to next-generation approaches. [PDF]
Elmenier FM +5 more
europepmc +1 more source
Evaluating zongertinib in the treatment of patients with HER2-mutant non-small cell lung cancer. [PDF]
Kim J, Ahn MJ.
europepmc +1 more source

